A newly published, peer-reviewed clinical study found that ButyraGen® significantly reduced belly pain, bloating, and gas—especially in women and post-menopausal women—while improving overall digestive quality of life. Results were seen in as little as one week, with benefits across both upper and lower GI symptoms.

ButyraGen® is a patent-pending, next-generation prebiotic that delivers butyrate directly to the small intestine—supporting gut barrier integrity, reducing inflammation, and enhancing digestive comfort. Unlike fiber-based prebiotics, it works independently of the gut microbiome, making it effective for a wider range of individuals.

Easily added to existing formulations, ButyraGen’s low water activity and low dose make it an ideal addition to gut health supplements, and research has shown a synergistic effect with certain probiotics.

Download the full white paper for clinical insights, real-world results, and formulation potential.